Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS

Clinical trial NCT00202995 · TERMINATED

Trial details

NCT number

NCT00202995

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.

Status

TERMINATED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2004-07-01

Primary completion

2007-10-01

Enrollment

91

View on ClinicalTrials.gov